In an industry-first, the company Synchron and Mount Sinai Hospital in New York have enrolled their first human patient in a U.S. clinical trial called COMMAND to evaluate an endovascular ...

NEW YORK--(BUSINESS WIRE)--Synchron, the brain-computer interface (BCI) company developing endovascular technology to restore functionality in individuals with motor impairment, today announced the ...

Brain chip technology advances rapidly as startups expand trials, raising ethical, safety, and privacy concerns worldwide.

New York-based Synchron, a brain-computer interface (BCI) company, announced it will be the first BCI company to reach native integration with Apple's new BCI Human Interface Device (BCI HID) profile ...

June 2 (UPI) --Paradromics, a competitor of Neuralink, announced Monday it safely implanted a brain-computer interface into a human patient and recorded neural activity, before removing it 10 minutes ...

New York-based Synchron, a brain-computer interface (BCI) company, has released a video showing an ALS patient using an iPad controlled entirely by thought in what it says is the "first-ever public ...

YORK, Pa. — A groundbreaking collaboration between tech company Synchron and Apple promises to transform the lives of people with severe mobility limitations through revolutionary brain-computer ...